BUZZ--美国股票走势-Soleno Therapeutics、Ideaya Biosciences、Profusa

路透中文
Apr 06
BUZZ--美国股票走势-<a href="https://laohu8.com/S/SLNO">Soleno Therapeutics</a>、Ideaya Biosciences、Profusa

个股移动的工作区搜索字符串:STXBZ

The Day Ahead 新闻通讯: https://refini.tv/3LI4BU7

新闻早报》通讯:https://refini.tv/3dKUyB8

路透4月6日 - 在上一交易日主要股指创下四个月来的最大单周涨幅之后,追踪标普500 指数和纳斯达克指数的期货 周一出现上扬 ,原因是投资者评估了中东冲突结束的前景。.N

** 埃克森美孚XOM.N

** 雪佛龙CVX.N

** 西方石油OXY.N

** 德文能源DVN.N

** Diamondback Energy FANG.O

** 康菲石油COP.N

** 贝克休斯 BKR.O

** SLB SLB.N

** 炼油厂 Marathon Petroleum MPC.N

** Phillips 66 PSX.N:BUZZ - 美国能源股下滑,因美伊和平建议导致油价下跌 nL4N40P0EH

** Profusa Inc PFSA.O:BUZZ - 因同意收购 PanOmics 诊断平台而跳涨 nL4N40P0FG

** Ideaya Biosciences Inc IDYA.O:BUZZ - 因开始进行早期癌症试验而上涨 nL4N40P0FM

** West Bancorporation Inc WTBA.O:BUZZ - 霍夫德对West Bancorporation的评级为 "市场表现"。 nL6N40P0AG

** Kratos Defense & Security Solutions Inc KTOS.O:BUZZ - 因增长潜力被杰富瑞上调至 "买入 "后上涨 nL4N40P0G2

** Rocket Companies Inc RKT.N

** First American Financial Corp FAF.N:BUZZ--巴克莱银行在Rocket和First American回调后将其评级提升至 "增持"。 nL6N40P0AM

** Playtika Holding Corp PLTK.O:BUZZ - 在宣布审查战略备选方案后上涨 nL4N40P0GB

** Nvidia Corp NVDA.O

** Advanced Micro Devices Inc AMD.O

** 高通公司 QCOM.O

** Broadcom Inc AVGO.O:BUZZ - 行业组织称,2月份全球芯片销售额猛增62%。 nL4N40P0HU

** Neurocrine Biosciences

** Soleno Therapeutics

BUZZ - Nuerocrine达成29亿美元收购交易,Soleno跳涨 nL4N40P0GZ

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10